Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease

NeuroToxicology

Volumn 23, Issue 4-5, 2002, Pages 515-519

  Kelada, Samir N ^a   Costa Mallen, Paola ^a   Costa, Lucio G ^a   Smith Weller, Terry ^a   Franklin, Gary M ^a   Swanson, Phillip D ^a   Longstreth Jr , W T ^a   Checkoway, Harvey ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Dopamine receptor; Gender; Monoamine oxidase A (MAO A); Monoamine oxidase B (MAO B); Parkinson's disease; Smoking

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE 2 RECEPTOR; TAQ POLYMERASE; TAQ1B POLYMERASE; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); ENDODEOXYRIBONUCLEASE ECORV; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADULT; AGE; AGED; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INCIDENCE; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; ARTICLE; CLINICAL TRIAL; ENZYMOLOGY; GENETICS; INFORMATION PROCESSING; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POPULATION; SEXUAL DEVELOPMENT; SMOKING;

GYMNOMYZA SAMOENSIS;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENOTYPE; HUMANS; INTRONS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; PARKINSON DISEASE; POPULATION; SEX CHARACTERISTICS; SMOKING;

EID: 0036777212     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00061-X     Document Type: Conference Paper

References (20)

1. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L, Inzitari D. Parkinson's disease and Parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 2000;55:1358-63.
2. Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa LG. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology 1998;50:1458-61.
3. Checkoway H, Powers KM, Smith-Weller T, Franklin GM, Longstreth Jr, WT, Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol use, and caffeine intake. Am J Epidemiol 2002;155:732-8.
4. Chevillard C, Barden N, Saavedra JM. Estradiol treatment decreases type A and increases type B monoamine oxidase in specific brain stem areas and cerebellum of ovariectomized rats. Brain Res 1981;222:177-81.
5. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 1997;74:154-6.
6. Costa-Mallen P, Checkoway H, Fishel M, Cohen AW, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease. Neurosci Lett 2000a;278:3-6.
7. Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism. J Neurol Neurosurg Psychiatry 2000b;69:535-7.
8. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor RR, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996a;379:733-6.
9. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 1996b;93:14065-9.
10. Hauptmann N, Shih JC. 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. Life Sci 2001;68:1231-41.
11. Hernan MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivi I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. Monoamine oxidase B intron 13 and catechol-O-methyltransferase codon 158 polymorphisms, cigarette smoking, and the risk of Parkinson's disease. Neurology 2002;58:1381-7.
12. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley, 2000.
13. Hotamisligil GS, Breakefield XO. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1991;49:383-92.
14. Khalil AA, Steyn S, Castagnoli Jr, N. Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves. Chem Res Toxicol 2000;13:31-5.
15. Kuppers E, Ivanova T, Karolczak M, Beyer C. Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons. J Neurocytol 2000;29:375-85.
16. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-72.
17. Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-7.
18. Mellick GD, McCann SJ, Le Couter DG. Parkinson's disease, MAO-B, and smoking. Neurology 1999;53:658.
19. Shih JC, Chen K, Ridd MJ. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 1999;22:197-217.
20. Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998;90:358-63.